In our first international episode, Dr. Peter Lu and Dr. Temara Hajjat cross the Atlantic (virtually) to talk to the illustrious Dr. Marc Benninga from Emma Children's Hospital/Academic Medical Centre in Amsterdam, the Netherlands. Dr. Benninga is not only our first guest from our sister society ESPGHAN, but also the first Olympian and perhaps the first with a Wikipedia page.
We bring in the European authority on pediatric constipation to talk about how he evaluates and treats children with constipation that has persisted despite our usual treatment with oral medications. We compare and contrast the practices in the United States and the Netherlands.
Learning Objectives
1) To understand different approaches to the evaluation of a child with constipation refractory to oral laxatives.
2) To understand the role of rectal irrigation in the treatment of a child with constipation refractory to oral laxatives.
3) To review the evidence on pelvic floor biofeedback therapy in children with suspected pelvic floor dyssynergia
4) To recognize the differences in practice among pediatric gastroenterologists in the evaluation and management of children with intractable constipation
CME for NASPGHAN members is available here!
As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.
Produced by: Peter Lu
This episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!
As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.
Check out our merch website!
Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.
Click here to support the show.